Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 13 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 11243213

    Kits and methods for prediction and treatment of preeclampsia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted

  2. US 11236122

    Triterpene amine derivatives

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  3. US 11236315

    Thermophile peptidoglycan hydrolase fusion proteins and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  4. US 11236161

    Chimeric antigen receptors targeting CD-19

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  5. US 11234953

    Ketone bodies to protect tissues from damage by ionizing radiation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  6. US 11235056

    Glycan-masked engineered outer domains of HIV-1 gp120 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  7. US 11235054

    Multivalent vaccine composition

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  8. US 11236151

    Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  9. US 11236152

    Neutralizing antibodies to HIV-1 GP41 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  10. US 11236171

    Human monoclonal antibodies specific for FLT3 and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  11. US 11230607

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  12. US 11225469

    Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  13. US 11207361

    AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  14. US 11207394

    Anti-mutated KRAS T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  15. US 11207315

    Emetine compounds for treatment and prevention of flavivirus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  16. US 11207339

    Targeted cancer therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  17. US 11208456

    Anti-KRAS-G12D T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  18. US 11202824

    Peptide fragments from filoviruses and their uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted

  19. US 11197879

    Flavonoid compositions and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  20. US 11191824

    Method of purifying virus-like-particles

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  21. US 11191727

    Multivalent nanoparticle-based vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  22. US 11191763

    HIV post-exposure prophylaxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  23. US 11191821

    Peptide vaccine formulations and use thereof for inducing an immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  24. US 11192903

    Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.